104 related articles for article (PubMed ID: 30190057)
1. Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33].
Derosa G; Cicero AFG; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Eur J Pharm Sci; 2018 Oct; 123():584. PubMed ID: 30190057
[No Abstract] [Full Text] [Related]
2. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Eur J Pharm Sci; 2014 Jan; 51():26-33. PubMed ID: 23999037
[TBL] [Abstract][Full Text] [Related]
3. Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
J Clin Pharm Ther; 2013 Feb; 38(1):48-55. PubMed ID: 23216584
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies": J Am Soc Hypertens 7 (2013) 32-39.
Derosa G; Cicero AFG; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
J Am Soc Hypertens; 2015 Oct; 9(10):821. PubMed ID: 30153105
[No Abstract] [Full Text] [Related]
6. Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
J Am Soc Hypertens; 2013; 7(1):32-9. PubMed ID: 23321403
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
Erdine S
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
Bolbrinker J; Huber M; Scholze J; Kreutz R
Fundam Clin Pharmacol; 2009 Dec; 23(6):767-74. PubMed ID: 19659504
[TBL] [Abstract][Full Text] [Related]
9. Retraction: 'Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies' by G. Derosa, A. F. G. Cicero, A. Carbone, F. Querci, E. Fogari, A. D'Angelo and P. Maffioli.
J Clin Pharm Ther; 2016 Apr; 41(2):237. PubMed ID: 27059120
[No Abstract] [Full Text] [Related]
10. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Redon J; Pichler G;
J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
Bilo G; Koch W; Hoshide S; Parati G
Hypertens Res; 2014 Sep; 37(9):836-44. PubMed ID: 24942766
[TBL] [Abstract][Full Text] [Related]
12. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study.
Susa N; Nishida Y; Yada Y; Nakayama T; Asai S; Takahashi Y
Clin Exp Hypertens; 2016; 38(2):173-9. PubMed ID: 26453437
[TBL] [Abstract][Full Text] [Related]
17. Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
Fogari R; Zoppi A; Mugellini A; Preti P; Perrone T; Maffioli P; Derosa G
Expert Opin Pharmacother; 2012 Apr; 13(5):629-36. PubMed ID: 22372508
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
Rohatagi S; Lee J; Shenouda M; Haworth S; Bathala MS; Allison M; Rubets I; Heyrman R; Noveck R; Salazar DE
J Clin Pharmacol; 2008 Nov; 48(11):1309-22. PubMed ID: 18974285
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.
Sievers P; Uhlmann L; Korkmaz-Icöz S; Fastner C; Bea F; Blessing E; Katus HA; Preusch MR
Drug Des Devel Ther; 2015; 9():3935-42. PubMed ID: 26251572
[TBL] [Abstract][Full Text] [Related]
20. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
Hoshino A; Nakamura T; Matsubara H
Clin Exp Hypertens; 2010; 32(7):416-22. PubMed ID: 20828223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
